Antibodies to tissue-type plasminogen activator in plasma from patients with primary antiphospholipid syndrome

British Journal of Haematology

Volumn 108, Issue 4, 2000, Pages 871-875

  Cugno, Massimo ^a   Dominguez, Miguel ^b   Cabibbe, Mara ^a   Bisiani, Giuliana ^a   Galli, Monica ^c   Angles Cano, Edouard ^b   Agostoni, Angelo ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b BICÊTRE HOSPITAL   (France)

^c OSPEDALI RIUNITI   (Italy)

Author keywords

Antibodies; Hypofibrinolysis; Primary antiphospholipid syndrome; Thrombosis; Tissue type plasminogen activator

Indexed keywords

AUTOANTIBODY; CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGED; ANALYTIC METHOD; ANTIBODY TITER; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBRINOLYSIS; HUMAN; IMMUNOASSAY; MALE; PRIORITY JOURNAL; THROMBOSIS;

ADULT; AGED; ANTIPHOSPHOLIPID SYNDROME; AUTOANTIBODIES; CASE-CONTROL STUDIES; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; THROMBOSIS; TISSUE PLASMINOGEN ACTIVATOR;

EID: 0034030512     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2000.01948.x     Document Type: Article

References (27)

1. Ames, P.R.J., Tommasino, C., Iannaccone, L., Brillante, M., Cimino, M. & Brancaccio, V. (1996) Coagulation activation and fibrinolytic imbalance in subjects with idiopathic antiphospholipid antibodies. A crucial role for acquired free protein S deficiency. Thrombosis and Haemostasis, 76, 190-194.
2. Anglés-Cano, E., Sultan, Y. & Clauvel, J.P. (1979) Predisposing factors to thrombosis in systemic lupus erythematosus. Journal of Laboratory and Clinical Medicine, 94, 312-323.
3. Asherson, R.A., Mackay, I.R. & Harris, E.N. (1986) Myocardial infarction in a young man with systemic lupus erythematosus, deep vein thrombosis, and antibodies to phospholipid. British Heart Journal, 56, 190-193.
4. Atsumi, T., Khamashla, M., Andujar, C., Leandro, M.J., Amengual, O., Ames, P.R.J. & Hughes, G.R.V (1998) Elevated plasma lipoprotein (a) level and its association with impaired fibrinolysis in patients with antiphospholipid syndrome. Journal of Rheum-tology, 25, 69-73.
5. Awada, H., Barlowatz-Maimon, G., Dougados, M., Maissoneuve, P., Sultan, Y. & Amor, B. (1988) Fibrinolysis abnormalities in systemic lupus erythematosus and their relation to vasculitis. Journal of Laboratory and Clinical Medicine, 111, 229-236.
6. Bevers, E.M., Galli, M., Barbui, T., Comfurius, P. & Zwaal, R.F.A. (1991) Lupus anticoagulant IgGs (LA) are not directed to phospholipids only, but to a complex of lipid-bound human prothrombin. Thrombosis and Haemostasis, 66, 629-632.
7. Bick, R.L. & Baker, W.F. (1994) Antiphospholipid and thrombosis syndromes. Seminars in Thrombosis and Hemostasis, 20, 3-15.
8. Brandt, J.T., Triplett, D.A., Alving, B. & Scharrer, I. (1995) Criteria for the diagnosis of lupus anticoagulants: an update. Thrombosis and Haemostasis, 74, 1185-1190.
9. Chantarangkul, V., Tripodi, A., Arbini, A. & Mannucci, P.M. (1992) Silica clotting time (SCT) as a screening and confirmatory test for detection of lupus anticoagulants. Thrombosis Research, 67, 355-365.
10. Collen, D. & Lijnen, H.R. (1991) Basic and clinical aspect of fibrinolysis and thrombolysis. Blood, 78, 3114-3124.
11. Cugno, M., Cicardi, M., Colucci, M., Bisiani, G., Merlini, P.A., Spinola, A., Paonessa, R. & Agostoni, A. (1996) Non neutralizing antibodies to tissue type plasminogen activator in the serum of acute myocardial infarction patients treated with the recombinant protein. Thrombosis and Haemostasia, 76, 234-238.
12. Cugno, M., Cattaneo, M., Bisiani, G., Cabibbe, M. & Martinelli, I. (1998) Absence of antibodies to tissue-type plasminogen activator in patients with previous deep vein thrombosis. International Journal of Clinical and Laboratory Research, 28, 72-73.
13. Exner, T., Rickard, K.A. & Kronenberg, H. (1978) Sensitive test demonstrating lupus anticoagulants and its behavioural patterns. British Journal of Haematology, 40, 143-151.
14. Ferro, D., Pittoni, V., Quintarelli, C., Basili, S., Saliola, M., Caroselli, C., Valesini, G. & Violi, F. (1997) Coexistence of anti-phospholipid antibodies and endothelial perturbation in systemic lupus erythematosus patients with ongoing prothrombotic state. Circulation, 95, 1425-1432.
15. Ferro, D., Quintarelli, C., Rasura, M., Antonini, G. & Violi, F. (1993) Lupus anticoagulant and fibrinolytic system in young patients with stroke. Stroke, 24, 368-370.
16. Fritzler, M., Hart, D., Wilson, D., De Garcìa-la Torre, I. & Salazar-Pàramo, M., Vàzquez-Del mercado, M., Senécal, J.L., Loyau, S. & Anglés-Cano, E. (1995) Antibodies to fibrin bound tissue type plasminogen activator in systemic sclerosis. Journal of Rheumatology, 22, 1688-1693.
17. Galli, M. & Barbui, T. (1999) Antiprothrombin antibodies: detection and clinical significance in the antiphospholipid syndrome. Blood, 93, 2149-2157.
18. Glas-Greenwalt, P., Kant, K.S., Allen, C. & Pollak, V. (1984) Fibrinolysis in health and disease: severe abnormalities in systemic lupus erythematosus. Journal of Laboratory and Clinical Medicine, 104, 962-976.
19. Hahn, B.H. (1991) Systemic lupus erythematosus. In: Harrison's Principles of Internal Medicine (ed. by J.D. Wilson, E. Braunwald, K.J. Isselbacher, R.G. Petersdorf, J.B. Martin, A.S. Fauci & R.K. Root), pp. 1432-1437. McGraw-Hill, New York.
20. Harris, E.N. (1990) Antiphospholipid antibodies. British Journal of Haematology, 74, 1-9.
21. Harris, E.N., Gharavi, A.E. & Hughes, C.R.V (1991) The anti-cardiolipin assay. In: Phospholipid-Binding Antibodies (ed. by E.N. Harris, T. Exner, G.R.V. Hughes & R.A. Asherson), pp. 175-187. CRC Press, Boca Raton, FL.
22. Juhan-Vague, I., Valadier, J., Alessi, M.C., Aillaud, M.F., Ansaldi, M.J., Philip-Joet, C., Holvoet, P., Serradimigni, A. & Collen, D. (1987) Deficient t-PA release and elevated PA inhibitor levels in patients with spontaneous or recurrent deep vein thrombosis. Thrombosis and Haemostasis, 57, 67-72.
23. Levine, S.R., Deegan, M.J., Futrell, N. & Welch, K.M.A. (1990) Cerebrovascular and neurologic disease associated with antiphospholipid antibodies: 48 cases. Neurology, 40, 1181-1189.
24. Lijnen, H.R. & Collen, D. (1989) Congenital and acquired deficiencies of components of the fibrinolytic system and their relation to bleeding or thrombosis. Fibrinolysis, 3, 67-77.
25. Loizou, S., McCrea, J.D., Rudge, A.C., Reynolds, R., Boyle, C.C. & Harris, E.N. (1985) Measurement of anticardiolipin antibodies by enzyme-linked immunosorbent assay: standardization and quantitation of results. Clinical and Experimental Immunology, 62, 738-744.
26. Mackworth-Young, C.G., Andreotti, F., Harmer, I., Loizou, S., Pottinger, B.E., Pearson, J.D., Davies G.J., Maseri, A. & Walport, M.J. (1995) Endothelium-derived haemostatic factors and the antiphospholipid syndrome. British Journal of Rheumatology, 34, 201-206.
27. Matsuura, E., Igarashi, Y., Yasuda, Triplett, D.A. & Koike, T. (1994) Anticardiolipin antibodies recognize β-glycoprotein I structure altered by interacting with an oxygen modified surface. Journal of Experimental Medicine, 179, 457-462.